Experience with Omalizumab for the treatment of chronic spontaneous urticaria in a tertiary center: real life experience.

Ayda Acar Bengu Gerceker Turk Ilgen Ertam Sagduyu Can Ceylan Gunseli Ozturk Idil Unal

Published in: Cutaneous and ocular toxicology (2020)

Our results show that omalizumab was an effective treatment for intractable CSU and did not cause any serious adverse effects other than asthenia, vertigo, and injection site reaction in four patients. These findings are relevant because they reflect real-life data.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
machine learning
combination therapy
peritoneal dialysis
big data
electronic health record
data analysis